IRIS
PISCIOTTA, LIVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.399
Totale 9.399
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.399
Totale 9.399
Salva come PNG Salva come JPEG
Città #
Genova 6.691
Genoa 1.162
Rapallo 1.041
Vado Ligure 464
Bordighera 41
Totale 9.399
Salva come PNG Salva come JPEG
Nome #
Lipoproteins, stroke and statins. 179
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 159
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 152
A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla) 134
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. 133
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 133
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. 131
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 128
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia. 126
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients. 125
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. 124
Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin. 123
An apparent inconsistency in parent to offspring transmission of point mutations of LDLR gene in familial hypercholesterolemia. 123
Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations. 121
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 121
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 120
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison. 120
The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia 117
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene 116
Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer 115
Genetic polymorphisms affecting the phenotypic expression in familial hypercholesterolemia 113
A “de novo” mutation of the LDL-receptor gene as the cause of familial hypercholesterolemia. 113
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs) 113
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 113
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 111
Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia. 111
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 111
Severe HDL deficiency due to novel defects in the ABCA1 transporter. 110
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia. 110
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. 110
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 109
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. 109
A silent mutation of Niemann-Pick C1-like 1 and apolipoprotein E4 modulate cholesterol absorption in primary hyperlipidemias. 109
A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. 109
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency. 109
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 109
Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia 109
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e. 108
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 108
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 108
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene 104
Two Italian Kindreds Carrying the Arg136>Ser Mutation of Apo E Gene: Development of Premature and Severe Atherosclerosis in the presence of Epsilon 2 as Second Allele 104
Molecular characterization of two patients with severe LCAT deficiency. 103
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency. 103
Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years. 102
Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs 102
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 102
Carotid ultrasonography in the assessment of cardiovascular risk 102
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 102
Long term substrate reduction therapy with ezetimibe alone or associated with statins in three adult patients with lysosomal acid lipase deficiency 99
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders 98
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 98
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. 93
Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene. 92
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 92
Denaturing high-performance liquid chromatography (DHPLC) in the detection of mutations of ABCA1 gene in Familial HDL Deficiency. 91
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. 91
Pharmacological treatment of a Sardinian patient affected by autosomal recessive hypercholesterolemia (ARH) 90
Changes in the Expression of the Nuclear Matrix Intermediate Filament Complex Proteins are correlated with the Level of Differentiation in Human Prostate Cancer. 87
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 87
Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants 85
Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients 85
Beta-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia. 84
Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia - Brief Report 82
Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia : a study of patients with familial hypercholesterolemia from Sardinia. 81
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. 81
Clinical Expression of Familial Hypercholesterolemia in clusters of mutations of LDL-receptor gene causing receptor-defective or receptor-negative phenotype 78
First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias 75
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 75
Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study 73
Lipoprotein Glomerulopathy: molecular chatacterization of three Italian patients and literature survey. 71
The study of familial hypercholesterolemia in Italy: A narrative review 70
Evaluation of RNA messangers involved in lipid trafficking of human intestinal cells by RT-PCR with competimer technology and microchip electrophoresis. 69
Troponin elevation does not always mean cardiac ischemia. 65
Characterization of Three Kindred with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 63
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 62
PCSK9 inhibitors for treating hypercholesterolemia 62
Two novel rare variants of APOA5 gene found in subjects with severe hypertrigliceridemia. 60
Le ipercolesterolemie familiari: forme dominanti e recessive (FH, FDB, FH3, FH4, ARH, beta-sitosterolemia, Deficit di 7alpha-idrossilasi). 59
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 57
A successful term pregnancy with severe hypertriglyceridaemia and acute pancreatitis. Clinical management and review of the literature 54
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 54
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 51
Diet and nutraceutical supplementation in dyslipidemic patients: First results of an italian single center real‐world retrospective analysis 51
Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies 49
null 49
Effect of statin treatment on arterial stiffness in individuals with newly-diagnosed Heterozygous Familial Hypercholesterolemia. 45
Homozygous familial hypercholesterolaemia in childhood – The first case report in Southeast Europe 43
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 43
LCAT deficiency: molecular and phenotypic characterization of an Italian family. 42
Evaluation of the efficacy of plant sterols supplement sterolip® ESI in patients with type IIA hypercholesterolemia in relation to Genetic variants modulating intestinal absorption of cholesterol 42
LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters 41
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 41
Effects of a mediterranean diet, dairy, and meat products on different phenotypes of dyslipidemia: A preliminary retrospective analysis 39
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 38
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity 37
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study 36
null 35
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study 32
Manuale di dietistica e dietetica applicata. Vol. 2 31
Totale 9.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.642
article - articoli 33.262
book - libri 95
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 285
Totale 67.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.991 0 0 0 161 198 245 320 180 220 380 225 62
2020/2021915 44 74 115 67 104 72 35 94 68 104 79 59
2021/20221.299 41 109 100 131 47 101 87 296 77 99 73 138
2022/20231.261 121 86 15 112 183 233 53 87 186 51 118 16
2023/2024994 38 90 22 105 109 188 60 65 36 57 87 137
2024/2025539 114 188 128 109 0 0 0 0 0 0 0 0
Totale 9.687